Desmoplakin (DSP, P15924) is a relevant drug target for the treatment of pneumonia, while SOD2 is used in the treatment of Hepatitis B. Currently, no drug targets have been found for the treatment of kidney and thyroid-related diseases. Here, SOD2 is linked to pneumonia.